DHI

DR Horton
D

DHI

Arincen52/100B

DR Horton free cash flow 1992–2026

DR Horton's free cash flow in Q4 FY2026, the three months to 30 September 2026, was 2.57B USD, up 6.0% on the same quarter a year before. DR Horton's free cash flow over the last twelve months was 3.35B USD, up 1.9% on the twelve months before. In fiscal year 2026 it was 3.35B USD, up 1.9% on the year before.

Last updated 6 Nov 2026 · Next report 19 Jan 2027

Free cash flow

Free cash flow · +20.2% a year over 10 yearsFree cash flow margin

Growth

Fiscal yearPeriod endingFree cash flowGrowthFree cash flow marginOperating cash flowCapital expenditureFree cash flow per share
TTM30 Sept 20263.35B+1.93%10.13%3.51B-160.40M11.71
FY202630 Sept 20263.35B+1.93%10.13%3.51B-160.40M11.71
FY202530 Sept 20253.28B+62.19%9.59%3.42B-137.40M10.60
FY202430 Sept 20242.02B-51.28%5.50%2.19B-165.30M6.11
FY202330 Sept 20234.16B+904.71%11.72%4.30B-148.60M12.10
FY202230 Sept 2022413.60M+54.91%1.24%561.80M-148.20M1.17
FY202130 Sept 2021267.00M-76.47%0.96%534.40M-267.40M0.73
FY202030 Sept 20201.13B+69.88%5.59%1.42B-286.80M3.07
FY201930 Sept 2019668.00M+40.01%3.80%892.10M-224.10M1.77
FY201830 Sept 2018477.10M+71.74%2.97%545.20M-68.10M1.24
FY201730 Sept 2017277.80M-47.77%1.97%435.10M-157.30M0.73
FY201630 Sept 2016531.90M-17.45%4.38%618.00M-86.10M1.42
FY201530 Sept 2015644.30M—5.95%700.40M-56.10M1.74
FY201430 Sept 2014-761.60M—-9.49%-661.40M-100.20M-2.08
FY201330 Sept 2013-1.29B—-20.59%-1.23B-58.00M-3.53
FY201230 Sept 2012-322.30M—-7.40%-288.70M-33.60M-0.90
FY201130 Sept 2011-1.40M-100.20%-0.04%14.90M-16.30M-0.00
FY201030 Sept 2010690.20M-39.19%15.69%709.40M-19.20M2.17
FY200930 Sept 20091.14B-39.41%31.03%1.14B-6.20M3.58
FY200830 Sept 20081.87B+42.38%28.19%1.88B-6.60M5.93
FY200730 Sept 20071.32B—11.65%1.36B-39.80M4.19
FY200630 Sept 2006-1.27B—-8.47%-1.19B-83.30M-4.03
FY200530 Sept 2005-688.90M—-4.97%-620.70M-68.20M-2.16
FY200430 Sept 2004-477.70M-227.51%-4.41%-422.50M-55.20M-1.51
FY200330 Sept 2003374.65M—4.29%423.32M-48.67M0.80
FY200230 Sept 2002-130.42M—-1.94%-90.60M-39.82M-0.46
FY200130 Sept 2001-88.65M—-1.99%-55.28M-33.37M-0.38
FY200030 Sept 2000-123.34M—-3.38%-107.55M-15.79M-0.54
FY199930 Sept 1999-188.20M—-5.96%-170.90M-17.30M-0.74
FY199830 Sept 1998-136.90M—-6.29%-125.30M-11.60M-0.68
FY199730 Sept 1997-88.40M—-10.56%-83.10M-5.30M-0.65
FY199630 Sept 1996-26.60M—-4.86%-23.90M-2.70M-0.23
FY199530 Sept 1995-34.70M—-7.93%-32.30M-2.40M-0.32
FY199430 Sept 1994-46.60M—-11.85%-44.00M-2.60M-0.47
FY199330 Sept 1993-20.30M-315.96%-10.68%-18.80M-1.50M-0.20
FY199230 Sept 19929.40M—7.57%10.00M-600.00K0.10

Figures in USD. Free cash flow is operating cash flow less capital expenditure. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Stock buybacks,Cash flow

Common questions about DR Horton's free cash flow

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.